Showing results (251-260 of 269) with videos related to

Sort By:
Pageof 27
The Lancet Regional Health. Europe|February 16, 2026
Multimorbidity phenotypes and associated characteristics in severe asthma: an observational study of European severe asthma registriesAnna Freeman, Saša Rink, Aruna T Bansal, et al.
Allergy|December 21, 2021
Development and validation of combined symptom-medication scores for allergic rhinitisBernardo Sousa-Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Pulmonology|July 28, 2025
Daily digital biomarkers in the follow-up and clustering of patients with asthmaBernardo Sousa-Pinto, Florence Schleich, Gilles Louis, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Allergy|May 14, 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important differenceBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Allergy|November 6, 2021
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paperTorsten Zuberbier, Tamara Dörr, Werner Aberer, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 26, 2024
Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAONikolaos G Papadopoulos, Adnan Custovic, Antoine Deschildre, et al.
Allergologie Select|September 11, 2020
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)HLudger Klimek, Oliver Pfaar, Margitta Worm, et al.
Pageof 27